EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Sevoflurane pretreatment alleviates hypoxia-reoxygenation-induced myocardial cell injury by upregulating miR-21-5p

Saiwen Qiu, Hui Chen, Qifang Jiang

Frontiers in Cardiovascular Medicine · 01.04.2025 · 12

DOI: 10.3389/fcvm.2025.1515160 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Frontiers in Cardiovascular Medicine, online erschienen am 01.04.2025. Verfasst von Saiwen Qiu und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Anesthesiology, Lanxi Traditional Chinese Medicine Hospital, Lanxi, Zhejiang, China. Die Arbeit wurde bisher 8-mal zitiert (Crossref) und nennt 41 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

This study investigates the preventive benefits of sevoflurane against myocardial ischemia-reperfusion (I/R) injury, focusing on its effect on the modulation of miR-21-5p.

Methods

In the clinical study, patients with a history of myocardial ischemia or other conditions requiring surgery were enrolled. Before surgery, the patients were anesthetized with either sevoflurane or propofol. The expression levels of IMA, H-FABP, IL-1β, TNF-α, and IL-6 were also examined. Additionally, the expression of miR-21-5p and its relationships with IMA and H-FABP. A cardiomyocyte hypoxia/reoxygenation (H/R) cell model was created for the in vitro tests. The cells were treated with or without sevoflurane and then transfected with inhibitors of miR-21-5p or a negative control (NC). Evaluations were conducted on cell viability, apoptosis ratio, and oxidative stress indicators (MDA, SOD, and ROS). Furthermore, the expression levels of miR-21-5p, apoptotic markers (BCL-2, BAX), myocardial damage markers (IMA, H-FABP), and inflammatory agents (TNF-α, IL-1β, IL-6) were quantified.

Results

In patients with a history of myocardial ischemia, sevoflurane reduced myocardial I/R injury. These patients also showed upregulation of miR-21-5p, which expression positively linked with levels of IMA. Moreover, in H/R treated cardiac cells, sevoflurane markedly reduced the expression of BAX, MDA, ROS, SOD, inflammatory factor and the apoptotic ratio. Nevertheless, inhibition of miR-21-5p abolished these protective effects. Furthermore, in H/R myocardial cells, sevoflurane increased BCL-2 expression and cell survival; these effects were also countered by blocking miR-21-5p.

Conclusion

Mechanistically, we demonstrate for the first time that sevoflurane alleviates myocardial cell injury in myocardial I/R by upregulating miR-21-5p, thereby reducing inflammation, apoptosis, and oxidative stress in myocardial cells. This finding provides a potential therapeutic target for improving myocardial I/R.

Schlagwörter

Stichwörter der Autor:innen

hypoxia/reoxygenationischemia reperfusionmiR-21-5pmyocardial protectionsevoflurane

Autor:innen und Institutionen

  • Department of Anesthesiology, Lanxi Traditional Chinese Medicine Hospital, Lanxi, Zhejiang, China.
  • Department of Anesthesiology, Lanxi People's Hospital, Lanxi, Zhejiang, China.

Zitieren

APA

Qiu, S., Chen, H., & Jiang, Q. (2025). Sevoflurane pretreatment alleviates hypoxia-reoxygenation-induced myocardial cell injury by upregulating miR-21-5p. Frontiers in Cardiovascular Medicine, 12. https://doi.org/10.3389/fcvm.2025.1515160

Vancouver

Qiu S, Chen H, Jiang Q. Sevoflurane pretreatment alleviates hypoxia-reoxygenation-induced myocardial cell injury by upregulating miR-21-5p. Frontiers in Cardiovascular Medicine. 2025;12. doi:10.3389/fcvm.2025.1515160

BibTeX
@article{Qiu2025,
  author = {Qiu, Saiwen and Chen, Hui and Jiang, Qifang},
  title = {Sevoflurane pretreatment alleviates hypoxia-reoxygenation-induced myocardial cell injury by upregulating miR-21-5p},
  journal = {Frontiers in Cardiovascular Medicine},
  year = {2025},
  volume = {12},
  doi = {10.3389/fcvm.2025.1515160}
}
Kostenlos starten →